Treatment of Hypertension with Nutrition and Nutraceutical Supplements: Part 1

. Wesa KM , Grimm RH . Recommendations and guidelines regarding the preferred research protocol for investigating the impact of an optimal healing environment on patients with hypertension. J Altern Complement Med, 2004; 10:S245–S250.

. Houston M. The role of nutrition and nutraceutical supplements in the treatment of hypertension. World J Cardiol, 2014; 6:38–66.

. Houston M. Nutrition and nutraceutical supplements for the treatment of hypertension: Part 1. J Clinical Hypertension, 2013; 15:752–757.

. Houston M. Nutrition and nutraceutical supplements for the treatment of hypertension: Part II. J Clinical Hypertension, 2013; 15:845–851.

. Houston M. Nutrition and nutraceutical supplements for the treatment of hypertension: Part III. J Clinical Hypertension, 2013; 15:931–937.

. Borghi C , Cicero AF . Nutraceuticals with a clinically detectable blood pressure-lowering effect: A review of available randomized clinical trials and their meta-analyses. Br J Clin Pharmacol, 2017; 83:163–171.

. Sirtori CR , Arnoldi A , Cicero AF . Nutraceuticals for blood pressure control. Ann Med, 2015; 47:447–456.

. Cicero AF , Colletti A . Nutraceuticals and blood pressure control: Results from clinical trials and meta-analyses. High Blood Press Cardiovasc Prev, 2015; 22:203–213.

. Turner JM , Spatz ES . Nutritional supplements for the treatment of hypertension: A practical guide for clinicians. Curr Cardiol Rep, 2016; 18:12–6.

. Caligiuri SP , Pierce GN . A review of the relative efficacy of dietary, nutritional supplements, lifestyle and drug therapies in the management of hypertension. Crit Rev Food Sci Nutr, 2017; 57:3508–3527.

. Houston MC , Fox B , Taylor N . What Your Doctor May Not Tell You About Hypertension. The Revolutionary Nutrition and Lifestyle Program to Help Fight High Blood Pressure. New York: AOL Time Warner, Warner Books, 2003.

. Houston MC. Handbook of Hypertension. Oxford: Wiley-Blackwell, 2009.

. Houston MC. What Your Doctor May Not Tell You About Heart Disease. New York: Grand Central Press, 2012.

. Sinatra S , Houston M , eds. Nutrition and Integrative Strategies in Cardiovascular Medicine. Boca Raton, FL: CRC Press, 2015.

. Chobanian AV , Bakris GL , Black HR , et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA, 2003; 289:2560–2572.

. Thomopoulos C , Parati G , Zanchetti A . Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels—Updated overview and meta-analyses of randomized trials. J Hypertens, 2016; 34:613–622.

. Ettehad D , Emdin CA , Kiran A , et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet, 2016; 387:957–967.

18. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens, 2013; 31:1925–1938.

. Flack JM , Calhoun D , Schiffrin EL . The New ACC/AHA hypertension guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults. Am J Hypertens, 2018; 31:133–135.

. Appel LJ. American Society of Hypertension Writing Group. ASH position paper: Dietary approaches to lower blood pressure. J Am Soc Hypertens, 2009; 3:321–331.

. Eaton SB , Eaton SB III , Konner MJ . Paleolithic nutrition revisited: A twelve-year retrospective on its nature and implications. Eur J Clin Nutr, 1997; 51:207–216.

. Layne J , Majkova Z , Smart EJ , et al. Caveolae: A regulatory platform for nutritional modulation of inflammatory diseases. J Nutr Biochem, 2011; 22:807–811.

. Dandona P , Ghanim H , Chaudhuri A , et al. Macronutrient intake induces oxidative and inflammatory stress: Potential relevance to atherosclerosis and insulin resistance. Exp Mol Med, 2010; 42:245–253.

. Kizhakekuttu TJ , Widlansky ME . Natural antioxidants and hypertension: Promise and challenges. Cardiovasc Ther, 2010; 28:e20–e32.

. Houston MC. New insights and approaches to reduce end organ damage in the treatment of hypertension: Subsets of hypertension approach. Am Heart J, 1992; 123:1337–1367.

. Nayak DU , Karmen C , Frishman WH , Vakili BA . Antioxidant vitamins and enzymatic and synthetic oxygen-derived free radical scavengers in the prevention and treatment of cardiovascular disease. Heart Dis, 2001; 3:28–45.

. Ritchie RH , Drummond GR , Sobey CG , et al. The opposing roles of NO and oxidative stress in cardiovascular disease. Pharmacol Res, 2017; 116:57–69.

. Russo C , Olivieri O , Girelli D , et al. Antioxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens, 1998; 16:1267–1271.

. Tse WY , Maxwell SR , Thomason H , et al. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J Hum Hypertens, 1994; 8:843–849.

. Galley HF , Thornton J , Howdle PD , et al. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci, 1997; 92:361–365.

. Dhalla NS , Temsah RM , Netticadam T . The role of oxidative stress in cardiovascular diseases. J Hypertens, 2000; 18:655–673.

. Loperena R , Harrison DG . Oxidative stress and hypertensive diseases. Med Clin North Am, 2017; 101:169–193.

. Pietri P , Vlachopoulos C , Tousoulis D . Inflammation and arterial hypertension: From pathophysiological links to risk prediction. Curr Med Chem, 2015; 22:2754–2761.

. Amer MS , Elawam AE , Khater MS , et al. Association of high-sensitivity C reactive protein with carotid artery intima-media thickness in hypertensive older adults. J Am Soc Hypertens, 2011; 5:395–400.

. Kvakan H , Luft FC , Muller DN . Role of the immune system in hypertensive target organ damage. Trends Cardiovasc Med, 2009; 19:242–246.

. Rodriguez-Iturbe B , Franco M , Tapia E , et al. Renal inflammation, autoimmunity and salt-sensitive hypertension. Clin Exp Pharmacol Physiol, 2012; 39:96–103.

. Mansego ML , Solar Gde M , Alonso MP , et al. Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension. J Hypertens, 2011; 29:492–500.

. Vongpatanasin W , Thomas GD , Schwartz R , et al. C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice. Circulation, 2007; 115:1020–1028.

39. Razzouk, Munter P , Bansilal S , et al. C reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention. Am Heart J, 2009; 158:277–283.

. Tian N , Penman AD , Mawson AR , et al. Association between circulating specific leukocyte types and blood pressure. The Atherosclerosis Risk in Communities (ARIC) study. J Am Soc Hypertens, 2010; 4:272–283.

. Muller DN , Kvakan H , Luft FC . Immune-related effects in hypertension and target-organ damage. Curr Opin Nephrol Hypertens, 2011; 20:113–117.

. Leibowitz A , Schiffin EL . Immune mechanisms in hypertension. Curr Hypertens Rep, 2011; 13:465–472.

. Xiong S , Li Q , Liu D , Zhu Z . Gastrointestinal tract: A promising target for the management of hypertension. Curr Hypertens Rep, 2017; 19:3–1.

. Caillon A , Mian MO , Fraulob-Aquino JC , et al. Gamma delta T cells mediate angiotensin II-induced hypertension and vascular injury. Circulation, 2017; 135:2155–2162.

. Rudemiller NP , Crowley SD . The role of chemokines in hypertension and consequent target organ damage. Pharmacol Res, 2017; 119:404–411.

. De Ciuceis C , Agabiti-Rosei C , Rossini C , et al. Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans. Blood Press, 2017; 26:237–245.

. Caillon A , Schiffrin EL . Role of inflammation and immunity in hypertension: Recent epidemiological, laboratory, and clinical evidence. Curr Hypertens Rep, 2016; 18:2–1.

. Abais-Battad JM , Dasinger JH , Fehrenbach DJ , Mattson DL . Novel adaptive and innate immunity targets in hypertension. Pharmacol Res, 2017; 120:109–115.

. Biancardi VC , Bomfim GF , Reis WL , et al. The interplay between angiotensin II, TLR4 and hypertension. Pharmacol Res, 2017; 120:88–96.

. Justin Rucker A , Crowley SD . The role of macrophages in hypertension and its complications. Pflugers Arch, 2017; 469:419–430.

51. Miller ER 3rd, Erlinger TP , Appel LJ . The effects of macronutrients on blood pressure and lipids: An overview of the DASH and OmniHeart trials. Curr Atheroscler Rep, 2006; 8:460–465.

52. Pérez-Ló pez FR , Chedraui P , Quadro JL . Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas, 2009; 64:67–79.

. Cutler JA , Follmann, Allender PS . Randomized trials of sodium reduction: An overview. Am J Clin Nutr, 1997; 65:643S–651S.

. Sacks FM , Svetkey LP , Vollmer WM , et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med, 2001; 4;344:3–10.

. Messerli FH , Schmieder RE , Weir MR . Salt: A perpetrator of hypertensive target organ disease?. Arch Intern Med, 1997; 157:2449–2452.

. Merino J , Guasch-Ferré M, Martínez-Gonzá lez MA , et al. Is complying with the recommendations of sodium intake beneficial for health in individuals at high cardiovascular risk? Findings from the PREDIMED study. Am J Clin Nutr, 2015; 101:440–448.

. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension, 1996; 27:481–490.

. Morimoto A , Usu T , Fujii T , et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet, 1997; 350:1734–1737.

. Kanbay M , Chen Y , Solak Y , Sanders PW . Mechanisms and consequences of salt sensitivity and dietary salt intake. Curr Opin Nephrol Hypertens, 2011; 20:37–43.

. Toda N , Arakawa K . Salt-induced hemodynamic regulation mediated by nitric oxide. J Hypertens, 2011; 29:415–424.

. Rust P , Ekmekcioglu C . Impact of salt intake on the pathogenesis and treatment of hypertension. Adv Exp Med Biol, 2017; 956:61–84.

. Toda N , Arakawa K . Salt-induced hemodynamic regulation mediated by nitric oxide. J Hypertens, 2011; 29:415–424.

. Foulquier S , Dupuis F , Perrin-Sarrado C , et al. High salt intake abolishes AT(2)-mediated vasodilation of pial arterioles in rats. J Hypertens, 2011; 29:1392–1399.

. Oberleithner H , Callies C , Kusche-Vihrog K , et al. Potassium softens vascular endothelium and increases nitric oxide release. Proc Natl Acad Sci U S A, 2009; 106:2829–2834.

. Feis J , Oberleithner H , Kusche-Vihrog K . Menage a trois: Aldosterone, sodium and nitric oxide in vascular endothelium. Biochim Biophys Acta, 2010; 1802:1193–1202.

. Yang Q , Liu T , Kuklina EV , et al. Sodium and potassium intake and mortality among US adults: Prospective data from the third National Health and Nutrition Examination Survey. Arch Int Med, 2011; 171:1183–1191.

. Houston MC , Harper KJ . Potassium, magnesium, and calcium: Their role in both the cause and treatment of hypertension. J Clin Hypertens, 2008; 10:3–11.

. Perez V , Chang ET . Sodium-to-potassium ratio and blood pressure, hypertension, and related factors. Adv Nutr, 2014; 5:712–741.

. Filippini T , Violi F , D' Amico R , Vinceti M . The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and metaanalysis. Int J Cardiol, 2017; 230:127–135.

. Gu D , He J , Xigui W , et al. Effect of potassium supplementation on blood pressure in Chinese: A randomized, placebo-controlled trial. J Hypertens, 2001; 19:1325–1331.

71. D' Elia L , Barba G , Cappuccio FP , Strazzullo P . Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. J Am Coll Cardiol, 2011; 57:1210–1219.

. Poorolajal J , Zeraati F , Soltanian AR , et al. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials. PLoS One, 2017; 12:e017496–7.

. Houston MC. The importance of potassium in managing hypertension. Curr Hypertens Rep, 2011; 13:309–317.

. Widman L , Wester PO , Stegmayr BG , Wirell MP . The dose dependent reduction in blood pressure through administration of magnesium: A double-blind placebo controlled cross-over trial. Am J Hypertens, 1993; 6:41–45.

. Laurant P , Touyz RM . Physiological and pathophysiological role of magnesium in the cardiovascular system: Implications in hypertension. J Hypertens, 2000; 18:1177–1191.

. Zhang X , Li Y , Del Gobbo LC , et al. Effects of magnesium supplementation on blood pressure: A meta-analysis of randomized double-blind placebo-controlled trials. Hypertension, 2016; 68:324–333.

. Kass L , Weekes J , Carpenter L . Effect of magnesium supplementation on blood pressure: A meta-analysis. Eur J Clin Nutr, 2012; 66:411–418.

. Houston MC. The role of magnesium in hypertension and cardiovascular disease. J Clin Hyperten, 2011; 13:843–847.

. Cormick G , Ciapponi A , Cafferata ML , Belizán JM. Calcium supplementation for prevention of primary hypertension. Cochrane Database Syst Rev, 2015; 6:CD01003–7.

. Resnick LM. Calcium metabolism in hypertension and allied metabolic disorders. Diabetes Care, 1991; 14:505–520.

. Garcia Zozaya JL , Padilla Viloria M . Alterations of calcium, magnesium, and zinc in essential hypertension: Their relation to the renin-angiotensin-aldosterone system. Invest Clin, 1997; 38:27–40.

. Hofmeyr GJ , Lawrie TA , Atallah AN , Duley L . Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev, 2010; 8:CD00105–9.

. Shahbaz AU , Sun Y , Bhattacharya SK , et al. Fibrosis in hypertensive heart disease: Molecular pathways and cardioprotective stratgies. J Hypetens, 2010; 28:S25–S32.

. Bergomi M , Rovesti S , Vinceti M , et al. Zinc and copper status and blood pressure. J Trace Elem Med Biol, 1997; 11:166–169.

. Stamler J , Elliott P , Kesteloot H , et al. Inverse relation of dietary protein markers with blood pressure. Findings for 10,020 men and women in the INTERSALT Study. INTERSALT Cooperative Research Group. INTERnational study of SALT and blood pressure. Circulation, 1996; 94:1629–1634.

. Altorf-van der Kuil W , Engberink MF , Brink EJ , et al. Dietary protein and blood pressure: A systematic review. PLoS One, 2010; 5;e12102–e12117.

. Jenkins DJ , Kendall CW , Faulkner DA , et al. Long-term effects of a plant-based dietary portfolio of cholesterol-lowering foods on blood pressure. Eur J Clin Nutr, 2008; 62:781–788.

. Rebholz CM , Friedman EE , Powers LJ , et al. Dietary protein intake and blood pressure: A meta-analysis of randomized controlled trials. Am J Epidemiol, 2012; 176:S27–S43.

. He J , Wofford MR , Reynolds K , et al. Effect of dietary protein supplementation on blood pressure: A randomized controlled trial. Circulation, 2011; 124;589–595.

. FitzGerald RJ , Murray BA , Walsh DJ . Hypotensive peptides from milk proteins. J Nutr, 2004:134:980S–988S.

. Pins JJ , Keenan JM . Effects of whey peptides on cardiovascular disease risk factors. J Clin Hypertens, 2006; 8:775–782.

. Aihara K , Kajimoto O , Takahashi R , Nakamura Y . Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr, 2005; 24:257–265.

. Gemino FW , Neutel J , Nonaka M , Hendler SS . The impact of lactotripeptides on blood pressure response in stage 1 and stage 2 hypertensives. J Clin Hypertens, 2010; 12:153–159.

. Geleijnse JM , Engberink MF . Lactopeptides and human blood pressure. Curr Opin Lipidol, 2010; 21:58–63.

. Pins J , Keenan J . The antihypertensive effects of a hydrolyzed whey protein supplement. Cardiovasc Drugs Ther, 2002; 16:6–8.

. Zhu CF , Li GZ , Peng HB , et al. Therapeutic effects of marine collagen peptides on Chinese patients with type 2 diabetes mellitus and primary hypertension. Am J Med Sci, 2010; 340:360–366.

. De Leo F , Panarese S , Gallerani R , Ceci LR . Angiotensin converting enzyme (ACE) inhibitory peptides: Production and implementation of functional food. Curr Pharm Des, 2009; 15:3622–3643.

. Lordan S , Ross P , Stanton C . Marine Bioactives as functional food ingredients: Potential to reduce the incidence of chronic disease. Mar Drugs, 2011; 9:1056–1100.

. Kawasaki T , Seki E , Osajima K , et al. Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J Hum Hypertens, 2000; 14:519–523.

. Kawasaki T , Jun CJ , Fukushima Y , Seki E . [Antihypertensive effect and safety evaluation of vegetable drink with peptides derived from sardine protein hydrolysates on mild hypertensive, high-normal and normal blood pressure subjects]. Fukuoka Igaku Zasshi, 2002; 93:208–218.

. Yang G , Shu XO , Jin F , et al. Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr, 2005; 81:1012–1017.

. Teede HJ , Giannopoulos D , Dalais FS , et al. Randomised, controlled, cross-over trial of soy protein with isoflavones on blood pressure and arterial function in hypertensive patients. J Am Coll Nutr, 2006; 25:533–540.

. Welty FK , Lee KS , Lew NS , Zhou JR . Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive and normotensive postmenopausal women. Arch Inter Med, 2007; 167:1060–1067.

. Mohanty DP , Mohapatra S , Misra S , et al. Milk derived bioactive peptides and their impact on human health. A review. J Biol Sci, 2016; 23:577–583.

. Nasca MM , Zhou JR , Welty FK . Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol, 2008; 102:84–86.

. He J , Gu D , Wu X , et al. Effect of soybean protein on blood pressue: A randomized, controlled trial. Ann Intern Med, 2005:143:1–9.

. Hasler CM , Kundrat S , Wool D . Functional foods and cardiovascular disease. Curr Atheroscler Rep, 2000; 2:467–475.

. Liu XX , Li SH , Chen JZ , et al. Effect of soy isoflavones on blood pressure: A meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis, 2012; 22:463–470.

. Begg DP , Sinclari AJ , Stahl LA , et al. Dietary proteins level interacts with omega-3 polyunsaturated fatty acid deficiency to induce hypertension. Am J Hyperten, 2010; 23:125–128.

110. Fekete ÁA, Giromini C , Chatzidiakou Y , et al. Whey protein lowers blood pressure and improves endothelial function and lipid biomarkers in adults with prehypertension and mild hypertension: Results from the chronic Whey2Go randomized controlled trial. Am J Clin Nutr, 2016; 104:1534–1544.

. Dong JY , Szeto IM , Makinen K , et al. Effect of probiotic fermented milk on blood pressure: A meta-analysis of randomised controlled trials. Br J Nutr, 2013; 110:1188–1194.

. Cicero AF , Gerocarni B , Laghi L , Borghi C . Blood pressure lowering effect of lactotripeptides assumed as functional foods: A meta-analysis of current available clinical trials. J Hum Hypertens, 2011; 25:425–436.

. Cicero AF , Aubin F , Azais-Braesco V , Borghi C . Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. Am J Hypertens, 2013; 26:442–449.

. Cicero AF , Rosticci M , Gerocarni B , et al. Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: A randomized double-blind clinical trial. Hypertens Res, 2011; 34:1035–1040.

. Morris MC. Dietary fats and blood pressure. J Cardiovasc Risk, 1994; 1:21–30.

. Siani A , Pagano E , Iacone R , et al. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens, 2000; 13:547–551.

. Vallance P , Leone A , Calver A , et al. Endogenous dimethyl-arginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol, 1992; 20:S60–S62.

. Ruiz-Hurtado G , Delgado C . Nitric oxide pathway in hypertrophied heart: New therapeutic uses of nitric oxide donors. J Hypertens, 2010; 28:56–61.

. Sonmez A , Celebi G , Erdem G , et al. Plasma apelin and ADMA levels in patients with essential hypertension. Clin Exp Hypertens, 2010; 32:179–183.

. Michell DL , Andrews KL , Chin-Dusting JP . Endothelial dysfunction in hypertension: The role of arginase. Front Biosci (Schol Ed), 2011; 3:946–960.

. Rajapakse NW , Mattson DL . Role of L-arginine in nitric oxide production in health and hypertension. Clin Exp Pharmacol Physiol, 2009; 36:249–255.

. Tsioufis C , Dimitriadis K , Andrikou E , et al. ADMA, C-reactive protein and albuminuria in untreated essential hypertension: A cross-sectional study. Am J Kidney Dis, 2010; 55:1050–1059.

. Facchinetti F , Saade GR , Neri I , et al. L-Arginine supplementation in patients with gestational hypertension: A pilot study. Hypertens Pregnancy, 2007; 26:121–130.

. Neri I , Monari F , Sqarbi L , et al. L-Arginine supplementation in women with chronic hypertension: Impact on blood pressure and maternal and neonatal complications. J Matern Fetal Neonatal Med, 2010; 23:1456–1460.

. Martina V , Masha A , Gigliardi VR , et al. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care, 2008; 31:940–944.

. Ast J , Jablecka A , Bogdanski I , et al. Evaluation of the antihypertensive effect of L-arginine supplementation in patients with mild hypertension assessed with ambulatory blood pressure monitoring. Med Sci Monit, 2010; 16:266–271.

. Schulman SP , Becker LC , Kass DA , et al. L arginine therapy in acute myocardial infraction: The vascular interaction with age in myocardial infarction (VINTAGE MI) randomized clinical trial. JAMA, 2006; 295:58–64.

. Dong JY , Qin JQ , Zhang ZL , et al. Effect of oral L-arginine supplementation on blood pressure: A meta-analysis of randomized, double-blind, placebo-controlled trials. Am Heart J, 2011; 162:959–965.

. Huxtable RJ. Physiologic actions of taurine. Physiol Rev, 1992; 72:101–163.

. Fujita T , Ando K , Noda H , et al. Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation, 1987; 75:525–532.

. Huxtable RJ , Sebring LA . Cardiovascular actions of taurine. Prog Clin Biol Res, 1983; 125:5–37.

. Tanabe Y , Urata H , Kiyonaga A , et al. Changes in serum concentrations of taurine and other amino acids in clinical antihypertensive exercise therapy. Clin Exp Hypertens, 1989; 11:149–165.

. Yamori Y , Taguchi T , Mori H , Mori M . Low cardiovascular risks in the middle age males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world. J Biomed Sci, 2010; 17:s21s2–6.

. Wang B , Li Y , Sun F , et al. Taurine supplementation lowers blood pressure and improves vascular function in prehypertension: Randomized, double-blind, placebo-controlled study. Hypertension, 2016; 67:541–549.

. Houston MC. Combination nutraceutical supplement lowers blood pressure in hypertensive individuals. Integr Med, 2013; 12:22–28.

. Sun Q , Wang B , Li Y , et al. Taurine supplementation lowers blood pressure and improves vascular function in prehypertension: Randomized, double-blind, placebo-controlled study. Hypertension, 2016; 67:541–549.

. Mori TA , Bao DQ , Burke V , et al. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension, 1999; 34:253–260.

138. Bø naa KH , Bjerve KS , Straume B , et al. Effect of eicosapentaenoic and docosahexanoic acids on blood pressure in hypertension: A population-based intervention trial from the Tromsø Study. N Engl J Med, 1990; 322:795–801.

. Mori TA , Burke V , Puddey I , Irish A . The effects of omega 3 fatty acids and coenzyme Q 10 on blood pressure and heart rate in chronic kidney disease: A randomized controlled trial. J Hypertens, 2009; 27:1863–1872.

. Ueshima H , Stamler J , Elliot B , Brown CQ . Food omega 3 fatty acid intake of individuals (total, linolenic acid, long chain) and their blood pressure: INTERMAP study. Hypertension, 2007; 50:313–319.

. Mon TA. Omega 3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physio, 2006; 33:842–846.

. Liu JC , Conkin SM , Manuch SB , et al. Long-chain omega-3 fatty acids and blood pressure. Am J Hypertens, 2011; 24:1121–1126.

. Engler MM , Schambelan M , Engler MB , Goodfriend TL . Effects of dietary gamma-linolenic acid on blood pressure and adrenal angiotensin receptors in hypertensive rats. Proc Soc Exp Biol Med, 1998; 218:234–237.

. Sagara M , Njelekela M , Teramoto T , et al. Effects of docoahexaenoic acid supplementation on blood pressure, heart rate, and serum lipid in Scottish men with hypertension and hypercholesterolemia. Int J Hypertens, 2011; 8:8091–8098.

. Colussi G , Catena C , Novello M , et al. Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes. Nutr Metab Cardiovasc Dis, 2017; 27:191–200.

. Miller PE , Van Elswyk M , Alexander DD . Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: A meta-analysis of randomized controlled trials. Am J Hypertens, 2014; 27:885–896.

. Pase MP , Grima NA , Sarris J . Do long-chain n-3 fatty acids reduce arterial stiffness? A meta-analysis of randomised controlled trials. Br J Nutr, 2011; 106:974–980.

. Cicero AF , Ertek S , Borghi C . Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management. Curr Vasc Pharmacol, 2009; 7:330–337.

. Minihane AM , Armah CK , Miles EA , et al. Consumption of fish oil providing amounts of eicosapentaenoic acid and docosahexaenoic acid that can be obtained from the diet reduces blood pressure in adults with systolic hypertension: A retrospective analysis. J Nutr, 2016; 146:516–523.

. Rodriguez-Leyva D , Weighell W , Edel AL , et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension, 2013; 62:1081–1089.

. Saravanan P , Davidson NC , Schmidt EB , Calder PC . Cardiovascular effects of marine omega-3 fatty acids. Lancet, 2010; 376:540–550.

. Alexander DD , Miller PE , Van Elswyk ME , et al. A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk. Mayo Clin Proc, 2017; 92:15–29.

. Ferrara LA , RaimondiS, d' Episcopa I . Olive oil and reduced need for antihypertensive medications. Arch Intern Med, 2000; 160:837–842.

. Perona JS , Canizares J , Montero E , et al. Virgin olive oil reduces blood pressure in hypertensive elderly patients. Clin Nutr, 2004; 23:1113–1121.

. Perona JS , Montero E , Sanchez-Dominquez JM , et al. Evaluation of the effect of dietary virgin olive oil on blood pressure and lipid composition of serum and low-density lipoprotein in elderly type 2 subjects. J Agric Food Chem, 2009; 57:11427–11433.

. Lopez-Miranda J , Perez-Jimenez F , Ros E , et al. Olive oil and health: Summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008. Nutr Metab Cardiovasc Dis, 2010; 20:284–294.

. Thomsen C , Rasmussen OW , Hansen KW , et al. Comparison of the effects on the diurnal blood pressure, glucose, and lipid levels of a diet rich in monounsaturated fatty acids with a diet rich in polyunsaturated fatty acids in type 2 diabetic subjects. Diabet Med, 1995; 12:600–606.

. Sofi F , Abbate R , Gensini GF , Casini A . Accruing evidence on benefits of adherence to the Mediterranean diet on health: An updated systematic review and meta-analysis. Am J Clin Nutr, 2010; 92:1189–1196.

. Estruch R , Ros E , Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med, 2013; 368:1279–1290.

. Nadtochiy SM , Redman EK . Mediterranean diet and cardioprotection: The role of nitrite, polyunsaturated fatty acids, and polyphenols. Nutrition, 2011; 27:733–744.

161. Salas-Salvadó J, Bulló M, Estruch R , et al. Prevention of diabetes with Mediterranean diets: A subgroup analysis of a randomized trial. Ann Intern Med, 2014; 160:1–10.

. Lopez S , Bermudez B , Montserrat-de la Paz S , et al. Virgin olive oil and hypertension. Curr Vasc Pharmacol, 2016; 14:323–329.

163. Martín-Pelá ez S , Castañ er O , Konstantinidou V , et al. Effect of olive oil phenolic compounds on the expression of blood pressure-related genes in healthy individuals. Eur J Nutr, 2017; 56:663–670.

. Storniolo CE , Casillas R , Bulló M, et al. A Mediterranean diet supplemented with extra virgin olive oil or nuts improves endothelial markers involved in blood pressure control in hypertensive women. Eur J Nutr, 2017; 56:89–97.

. Hohmann CD , Cramer H , Michalsen A , et al. Effects of high phenolic olive oil on cardiovascular risk factors: A systematic review and meta-analysis. Phytomedicine, 2015; 22:631–640.

166. Domé nech M , Roman P , Lapetra J , et al. Mediterranean diet reduces 24-hour ambulatory blood pressure, blood glucose, and lipids: One-year randomized, clinical trial. Hypertension, 2014; 64:69–76.

. Lockyer S , Rowland I , Spencer JP , et al. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: A randomized controlled trial. Eur J Nutr, 2017; 56:1421–1432.

. Cabrera-Vique C , Navarro-Alarcón M , Rodríguez Martínez C , Fonollá-Joya J . Hypertensive effect of an extract of bioactive compounds olive leaves preliminary clinical study. Nutr Hosp, 2015; 32:242–249.

. Susalit E , Agus N , Effendi I , et al. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: Comparison with Captopril. Phytomedicine, 2011; 18:251–258.

. Flynn M , Wang S . Olive oil as medicine: The effect on blood pressure. The Report of UCD Olive Center, December 2015.

. Psaltopoulou T , Naska A , Orfanos P , et al. Olive oil, the Mediterranean diet, and arterial blood pressure: The Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr, 2004; 80:1012–1018.

. Toledo E , Hu FB , Estruch R , et al. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: Results from a randomized controlled trial. BMC Med, 2013; 11:20–7.

. Perrinjaquet-Moccetti T , Busjahn A , Schmidlin C , et al. Food supplementation with an olive (Olea uropaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother Res, 2008; 22:1239–1242.

. Davis CR , Hodgson JM , Woodman R , et al. A Mediterranean diet lowers blood pressure and improves endothelial function: Results from the MedLey randomized intervention trial. Am J Clin Nutr, 2017; 105:1305–1313.

. Miura K , Stamler J , Brown IJ , et al. INTERMAP Research Group Relationship of dietary monounsaturated fatty acids to blood pressure: The International Study of Macro/Micronutrients and Blood Pressure. J Hypertens, 2013; 31:1144–1150.

. Perrinjaquet-Moccetti T , Busjahn A , Schmidlin C , et al. Food supplementation with an olive (Olea europaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother Res, 2008; 22:1239–1242.

. Sherman DL , Keaney JF , Biegelsen ES , et al. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension, 2000; 35:936–941.

. Ness AR , Khaw K-T , Bingham S , Day NE . Vitamin C status and blood pressure. J Hypertens, 1996; 14:503–508.

. Duffy SJ , Bokce N , Holbrook M , et al. Treatment of hypertension with ascorbic acid. Lancet, 1999; 354:2048–2049.

. Enstrom JE , Kanim LE , Klein M . Vitamin C intake and mortality among a sample of the United States population. Epidemiology, 1992; 3:194–202.

. Block G , Jensen CD , Norkus EP , et al. Vitamin C in plasma is inversely related to blood pressure and change in blood pressure during the previous year in young black and white women. Nut J, 2008; 17:35–46.

. Hatzitolios A , Iliadis F , KatsikiN, Baltatzi M. Is the antihypertensive effet of dietary supplements via aldehydes reduction evidence based: A systemic review. Clin Exp Hypertens, 2008:30;628–639.

. Mahajan AS , Babbar R , Kansai N , et al. Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension. J CLin Biochem Nutr, 2007; 402;141–147.

. Ledlerc PC , Proulx CD , Arquin G , Belanger S . Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II. Am J Hypertens, 2008:21:67–71.

. Plantinga Y , Ghiadone L , Magagna A , Biannarelli C . Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens, 2007; 20:392–397.

. Sato K , Dohi Y , Kojima M , Miyagawa K . Effects of ascorbic acid on ambulatory blood pressure in elderly patients with refractory hypertension. Arzneimittelforschung, 2006; 56:535–540.

. Block G , Mangels AR , Norkus EP , et al. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension, 2001; 37:261–267.

. McRae MP. Is Vitamin C an effective antihypertensive supplement? A review and analysis of the literature. J Chiropr Med, 2006; 5:60–64.

. Simon JA. Vitamin C and cardiovascular disease: A review. J Am Coll Nutr, 1992; 11:107–125.

. Ness AR , Chee D , Elliott P . Vitamin C and blood pressure—An overview. J Hum Hypertens, 1997; 11:343–350.

. Trout DL. Vitamin C and cardiovascular risk factors. Am J Clin Nutr, 1991; 53:322S–325S.

. Ried K , Travica N , Sali A . The acute effect of high-dose intravenous vitamin C and other nutrients on blood pressure: A cohort study. Blood Press Monit, 2016; 21:160–167.

. Buijsse B , Jacobs DR Jr , Steffen LM , et al. Plasma ascorbic acid, a priori diet quality score, and incident hypertension: A prospective cohort study. PLoS One, 2015; 10:e014492–0.

. Hajjar IM , George V , Sasse EA , Kochar MS . A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther, 2002; 9:289–293.

. National Center for Health Statistics , Fulwood R , Johnson CL , Bryner JD . Hematological and nutritional biochemistry reference data for persons 6 months–74 years of age: United States, 1976–80. Washington, DC; US Public Health Service; 1982 Vital and Health Statistics series 11, No. 232, DHHS publication no. (PHS) 83-1682.

. McCartney DM , Byrne DG , Turner MJ . Dietary contributors to hypertension in adults reviewed. Ir J Med Sci, 2015; 184:81–90.

. Enstrom JE , Kanim LE , Klein M . Vitamin C intake and mortality among a sample of the United States population. Epidemiology, 1992; 3:194–202.

. Block G , Jensen CD , Norkus EP , et al. Vitamin C in plasma is inversely related to blood pressure and change in blood pressure during the previous year in young black and white women. Nutr J, 2008; 17:35–46.

. Juraschek SP , Guallar E , Appel LJ , Miller ER 3rd. Effects of vitamin C supplementation on blood pressure: A meta-analysis of randomized controlled trials. Am J Clin Nutr, 2012; 95:1079–1088.

. Ward NC , Wu JH , Clarke MW , Puddy IB . The effect of vitamin E on blood pressure in individuals with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. J Hypertens, 2007; 25:227–234.

. Murray ED , Wechter WJ , Kantoci D , et al. Endogenous natriuretic factors 7: Biospecificity of a natriuretic gamma-tocopherol metabolite LLU alpha. J Pharmacol Exp Ther, 1997; 282:657–662.

. Gray B , Swick J , Ronnenberg AG . Vitamin E and adiponectin: Proposed mechanism for vitamin E-induced improvement in insulin sensitivity. Nutr Rev, 2011; 69:155–161.

. Kuwabara A , Nakade M , Tamai H , et al. The association between vitamin E intake and hypertension: Results from the re-analysis of the National Health and Nutrition Survey. J Nutr Sci Vitaminol (Tokyo), 2014; 60:239–245.

. Hodgson JM , Croft KD , Woodman RJ , et al. Effects of vitamin E, vitamin C and polyphenols on the rate of blood pressure variation: Results of two randomised controlled trials. Br J Nutr, 2014; 112:1551–1561.

. Houston MC. Vascular Biology in Clinical Practice. Philadelphia, PA: Hanley and Belfus, 2000.

. Houston M. Handbook of Hypertension. Oxford UK: Wiley Blackwell, 2009.